NVO is trading at $45.40, up 5.1% versus the comparison close of $43.19 during regular trading. This is a price-movement alert; no separate company-specific catalyst was searched for this follow-up.
🟢 Novo Nordisk A/S extends move to 5.1% up
Novo Nordisk A/S
Related News
NVO
Novo Nordisk expects generic semaglutide in China by 2027, as protections end
NVO
Novo Nordisk Foundation launches $69M hub, accelerating European obesity drug discovery
NVO
🟢 Novo Nordisk A/S is trading 4.3% up today on plans to seek Chinese approval for oral Wegovy
NVO
Novo Nordisk seeks China approval for oral Wegovy, challenging Eli Lilly
NVO